These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8868446)

  • 1. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies.
    Little SF; Novak JM; Lowe JR; Leppla SH; Singh Y; Klimpel KR; Lidgerding BC; Friedlander AM
    Microbiology (Reading); 1996 Mar; 142 ( Pt 3)():707-715. PubMed ID: 8868446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.
    Little SF; Leppla SH; Friedlander AM
    Infect Immun; 1990 Jun; 58(6):1606-13. PubMed ID: 2111283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.
    Gubbins MJ; Berry JD; Corbett CR; Mogridge J; Yuan XY; Schmidt L; Nicolas B; Kabani A; Tsang RS
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):436-43. PubMed ID: 16872381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F; Lévy M; Landier A; Lafaye P; Mock M
    Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
    Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1.
    Rivera J; Nakouzi A; Abboud N; Revskaya E; Goldman D; Collier RJ; Dadachova E; Casadevall A
    Infect Immun; 2006 Jul; 74(7):4149-56. PubMed ID: 16790789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
    Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.
    Thullier P; Avril A; Mathieu J; Behrens CK; Pellequer JL; Pelat T
    PLoS One; 2013; 8(5):e65855. PubMed ID: 23741517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the immune response to the lethal toxin of Bacillus anthracis].
    Belova EV; Kolesnikov AV; Zakharova MIu; Dubileĭ SA; Diatlov IA; Shemiakin IG
    Bioorg Khim; 2008; 34(5):639-44. PubMed ID: 19060938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.
    Abboud N; De Jesus M; Nakouzi A; Cordero RJ; Pujato M; Fiser A; Rivera J; Casadevall A
    J Biol Chem; 2009 Sep; 284(37):25077-86. PubMed ID: 19617628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies.
    Little SF; Leppla SH; Burnett JW; Friedlander AM
    Biochem Biophys Res Commun; 1994 Mar; 199(2):676-82. PubMed ID: 8135809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.
    Chen Z; Moayeri M; Crown D; Emerson S; Gorshkova I; Schuck P; Leppla SH; Purcell RH
    Infect Immun; 2009 Sep; 77(9):3902-8. PubMed ID: 19528217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of protease-treated Bacillus anthracis protective antigen.
    Novak JM; Stein MP; Little SF; Leppla SH; Friedlander AM
    J Biol Chem; 1992 Aug; 267(24):17186-93. PubMed ID: 1512256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.